CDK6 and medulloblastoma: miR-129 can regulate multiple tumor cell lines and primary tumors including medulloblastoma, undifferentiated gastric cancers, lung adenocarcinoma, endometrial cancer and colorectal carcinoma through down-regulating CDK6 expression [44].